Stemgent Announces Sponsorship of Harvard Stem Cell Institute Seminar Series;
BOSTON, Sept. 1 /PRNewswire/ — Stemgent, Inc. announced today that it has pledged a financial gift to the Harvard Stem Cell Institute (HSCI) Seminar Series Fund in support of the HSCI 2009 – 2010 Seminar Series. Terms of the gift were not disclosed.
The HSCI Seminar Series is an educational program for the stem cell science community in which pioneers in the national and international realm of stem cell research, including many from the Harvard-affiliated senior faculty, present contemporary stem cell topics. Speakers are nominated by HSCI faculty and selected by the HSCI. The series are typically well attended and are recognized for fostering collaboration within the HSCI community as well as involving participation from the global stem cell scientific population.
“We’re pleased to be able to fund this prestigious seminar series and we’re very proud of our ongoing relationship with HSCI through our Scientific Advisory Board which includes Harvard’s Lee Rubin and Doug Melton, ” said Ian Ratcliffe, Stemgent’s president and chief executive officer. ” HSCI has a top-notch research team, displays a global scientific acumen and it’s always a great pleasure to work with them.”
Brock Reeve, Executive Director of HSCI, commented, “The HSCI Seminar Series is focused on enabling scientific interchange among experts in the stem cell field from around the world. HSCI is very pleased that Stemgent, a company focused on addressing the needs of stem cell scientists, has agreed to partner with us by supporting this series.”
About the Harvard Stem Cell Institute
Founded in 2004, the Harvard Stem Cell Institute (HSCI) is a scientific collaborative that brings together researchers from across Harvard’s many affiliated hospitals, institutes, and schools to accelerate stem cell science from the laboratory bench to the patient bedside. With 72 Principal Faculty and 146 Affiliate Faculty, the HSCI represents the world’s largest concentration of stem cell researchers. Using philanthropic dollars, HSCI provides three programs of support for its community: a Research Grant program; an Ethics and Policy Program; and, an Education Program. For more information, please visit http://www.hsci.harvard.edu.
Stemgent advances stem cell science by providing proprietary reagents and tools developed by some of the world’s leading stem cell scientists. Stemgent’s product offering has been specifically optimized for and screened against stem cells, and includes small molecules for pluripotency, self-renewal, and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies, transfection reagents, and more. This unique product mix is designed to serve researchers who study stem cell biology and regenerative medicine, and those who use cells derived from stem cells as tools to advance their understanding of major diseases. With dual headquarters in Boston, MA, and San Diego, CA, Stemgent is well positioned to serve these major research markets. For more information, please visit http://www.stemgent.com.
SOURCE Stemgent, Inc.